| Estimated peptide |
Comparative Analysis |
|
| Ratio |
||
| F4404 vs. SM |
F4408 vs. SM |
|
| Ala-Ser Thr-Gly |
3.5 |
3.4 |
| Ala-Thr Thr-Ala |
<1 |
<1 |
| Arg-Glu Glu-Arg |
<1 |
<1 |
| Arg-Gly Gly-Arg |
<1 |
<1 |
| Arg-Pro |
<1 |
<1 |
| Asn-Asp Asp-Asn |
1.1 |
1.8 |
| Asn-Ile Asn-Leu Ile-Asn Leu-Asn Val-Gln |
N.A. |
1< |
| Asn-Thr Ser-Gln Thr-Asn |
<1 |
<1 |
| Asp-Arg |
1.2 |
1.3 |
| Asp-Asp |
<1 |
4.2 |
| Asp-Glu |
<1 |
1.4 |
| Asp-Gly |
0.7 |
0.8 |
| Asp-Lys |
0.9 |
1.1 |
| Asp-Ser Ser-Asp |
<1 |
<1 |
| Daminozide Ala-Ala |
22 |
15 |
| Glu-Asp |
<1 |
1.1 |
| Glu-Glu |
<1 |
0.5 |
| Glu-Ser |
<1 |
0.7 |
| Gly-Asp |
<1 |
1.0 |
| Gly-Gly |
N.A. |
1< |
| Gly-His His-Gly |
<1 |
<1 |
| Gly-Lys Lys-Gly |
<1 |
0.9 |
| Ile-Ala Leu-Ala |
N.A. |
1< |
| Ile-Lys Lys-Ile Lys-Leu Leu-Lys |
<1 |
0.5 |